Skip to Main Content

Paper Details

Genomics and drug profiling of fatal TCF3-HLF-positive acute lymphoblastic leukemia identifies recurrent mutation patterns and therapeutic options.
Nat Genet
161
2015
ABT-199, ALL, BCL2, BCL2-specific, HLF, HLF ALL, PAX5, PAX5 gene, PBX1, TCF3, TCF3-, TCF3-HLF ALL, VPREB1, anthracyclines, hybrid, drug-resistant hematopoietic state, lymphoid-committed cell, lymphoid-committed cell of origin, non-, patient, translocated allele, treatment-responsive TCF3-PBX1-, venetoclax
Author NameAffiliation
Ute FischerClinic for Pediatric Oncology, and Clinical Immunology, Heinrich-Heine-University
Thomas RischMax Planck Institute for Molecular Genetics
Hans-J??rg WarnatzMax Planck Institute for Molecular Genetics
Michael GombertClinic for Pediatric Oncology, and Clinical Immunology, Heinrich-Heine-University
Adrian M St??tz
Vyacheslav AmstislavskiyMax Planck Institute for Molecular Genetics
Mauro DelorenziLudwig Center for Cancer Research, University of Lausanne
Mauro DelorenziSwiss Institute for Bioinformatics (SIB)
Cornelia EckertCharite University Hospital
Christian P KratzHannover Medical School
Alice C McHardyHeinrich-Heine-University
Alice C McHardyHeinrich-Heine-University
Anthony V MoormanNorthern Institute of Cancer Research, Newcastle University
Benjamin Raeder
Philip RosenstielInstitute of Clinical Molecular Biology, Christian-Albrechts-University of Kiel
Stefan SchreiberInstitute of Clinical Molecular Biology, Christian-Albrechts-University of Kiel
Arndt BorkhardtClinic for Pediatric Oncology, and Clinical Immunology, Heinrich-Heine-University
Arndt BorkhardtClinic for Pediatric Oncology, and Clinical Immunology, Heinrich-Heine-University
Andre FrankeInstitute of Clinical Molecular Biology, Christian-Albrechts-University of Kiel
Andre FrankeInstitute of Clinical Molecular Biology, Christian-Albrechts-University of Kiel
Jan O Korbel
Jan O Korbel
Marie-Laure YaspoMax Planck Institute for Molecular Genetics
  • 1 - 23

Datasets